Analysed VIVOSIM LABS INC (VIVS:NASDAQ) News Sources
VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs
24-03-2026
yahoo.com
VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales
03-03-2026
yahoo.com
VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego
11-02-2026
yahoo.com
What is the current price of VIVOSIM LABS INC (VIVS:NASDAQ)?
The current price of VIVOSIM LABS INC (VIVS:NASDAQ) is $1.4603.
VIVOSIM LABS INC (VIVS:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIVOSIM LABS INC (VIVS:NASDAQ) since the previous trading day is $-0.0797.
VIVOSIM LABS INC (VIVS:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIVOSIM LABS INC (VIVS:NASDAQ) since the previous trading day is -5.1753%.
What is the most recent average sentiment score for VIVOSIM LABS INC (VIVS:NASDAQ)?
The most recent average sentiment score for VIVOSIM LABS INC (VIVS:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for VIVOSIM LABS INC (VIVS:NASDAQ)?
The most recent sentiment for VIVOSIM LABS INC (VIVS:NASDAQ) is .
SEC-8K** Filing Available For VIVOSIM LABS INC (VIVS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.